The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers

NCT02889822 Phase 1 COMPLETED

Conducted in Chinese healthy adult volunteers,the study aims to observe the safety and tolerability of single/multiple-dose administration of different doses of Alprostadil Liposome for Injection as well as to confirm the safety dose range.

Details

Lead sponsor	Guangzhou Yipinhong Pharmaceutical CO.,LTD
Phase	Phase 1
Status	COMPLETED
Enrolment	44
Start date	2010-03
Completion	2010-12

Conditions

• Cardiovascular Diseases

Interventions

• Alprostadil Liposomes for Injection

Primary outcomes

• Safety assessment of Alprostadil Liposome for Injection — 14 days
  The safety assessment for this study include: 1. Adverse event（AEs） 2. Change from baseline in physical examination,vital signs,laboratory examinations 3. Local irritation symptoms

Countries

China